Medical Market Report

Global In Vitro Toxicology Testing Market By Type (Cellular Assay, Biochemical Assay, In Silica, and Ex-vivo), By Application (Systemic Toxicology, Dermal Toxicity, Endorine Disruption, and Occular Toxicity), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 139140
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global In Vitro Toxicology Testing Market is estimated to be valued US$ XX.X million in 2019. The report on In Vitro Toxicology Testing Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global in vitro toxicology testing market is segmented on the basis of Type, Application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    In Vitro Toxicology Testing Market Scope:

    By type, the market is segmented into Cellular Assay, Biochemical Assay, In Silica, and Ex-vivo. By Application, the market is divided into Systemic Toxicology, Dermal Toxicity, Endorine Disruption, and Occular Toxicity.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Abbott, Covance, GE Healthcare, Quest Diagnostics Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Catalent Pharma Solutions, Cyprotex, Agilent Technologies, Charles River Laboratories, Merck KgaA, and Eurofins Scientific Inc..

    Key Market Segments

    Type

    Cellular Assay

    Biochemical Assay

    In Silica

    Ex-vivo

    Application

    Systemic Toxicology

    Dermal Toxicity

    Endorine Disruption

    Occular Toxicity

    Key Market Players included in the report:

    Abbott

    Covance

    GE Healthcare

    Quest Diagnostics Inc.

    Thermo Fisher Scientific Inc.

    Bio-Rad Laboratories

    Catalent Pharma Solutions

    Cyprotex

    Agilent Technologies

    Charles River Laboratories

    Merck KgaA

    Eurofins Scientific Inc.

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and In Vitro Toxicology Testing Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of In Vitro Toxicology Testing Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers In Vitro Toxicology Testing Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global In Vitro Toxicology Testing Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the In Vitro Toxicology Testing Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the In Vitro Toxicology Testing Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of In Vitro Toxicology Testing sub-markets, depending on key regions (various vital states).
    To analyze In Vitro Toxicology Testing Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the In Vitro Toxicology Testing Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide In Vitro Toxicology Testing Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. In Vitro Toxicology Testing Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global In Vitro Toxicology Testing Market Overview
    

    3.1. In Vitro Toxicology Testing Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global In Vitro Toxicology Testing Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global In Vitro Toxicology Testing Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Cellular Assay
    

      4.4. Biochemical Assay
    

      4.5. In Silica
    

      4.6. Ex-vivo
    

    5. Global In Vitro Toxicology Testing Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global In Vitro Toxicology Testing Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Systemic Toxicology
    

      5.4. Dermal Toxicity
    

      5.5. Endorine Disruption
    

      5.6. Occular Toxicity
    

    6. Global In Vitro Toxicology Testing Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America In Vitro Toxicology Testing Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe In Vitro Toxicology Testing Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific In Vitro Toxicology Testing Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America In Vitro Toxicology Testing Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa In Vitro Toxicology Testing Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global In Vitro Toxicology Testing Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Abbott
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Covance
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. GE Healthcare
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Quest Diagnostics Inc.
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Thermo Fisher Scientific Inc.
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. Bio-Rad Laboratories
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. Catalent Pharma Solutions
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. Cyprotex
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Agilent Technologies
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. Charles River Laboratories
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

      7.13. Merck KgaA
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments
    

      7.14. Eurofins Scientific Inc.
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.